Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Beth Israel Deaconess Medical Center
Ohio State University Comprehensive Cancer Center
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
Columbia University
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Louisville
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fate Therapeutics
University of California, San Francisco
National Cancer Institute (NCI)
Northwestern University
University of Rochester